纳米粒子增强的多糖在药物输送系统中的水凝:对近期进展的回顾
Sami A Al-Hussain1, Aeysha Sultan2, Laila Rubab3
1Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
International journal of biological macromolecules
|November 26, 2025
概括
聚糖化纳米粒子水凝提供了先进的药物输送,具有改进的机制和有针对性的释放. 克服批量变性等挑战是癌症和伤口愈合的临床应用的关键.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 传统的水凝在药物输送方面存在局限性.
- 多糖纳米颗粒增强水凝的性能,如机械强度和药物释放.
- 多糖为有针对性的相互作用提供了内在的生物活性.
研究的目的:
- 审查用于药物输送的多糖胺纳米粒子载荷液体的近期进展.
- 讨论配方,结构-功能关系和应用.
- 突出临床翻译的挑战和未来方向.
主要方法:
- 将纳米级的多糖体构建块集成到3D水凝网络中.
- 利用固有的多糖生物活性 (氨酸,奇托桑,酸盐).
- 审查在瘤学,伤口再生和治疗学中的应用.
主要成果:
- 在机械强度,封装效率和受控释放方面的协同改进.
- 启用了选择性组织相互作用和微环境引导的分娩.
- 在各种生物医学领域的应用性已被证明,提高了治疗精度.
结论:
- 多糖纳米粒子水凝显示出对先进疗法的重大前景.
- 解决批量变异性,分散稳定性和标准化对于临床翻译至关重要.
- 未来的工作应该集中在跨平台的标准和个性化医疗的整合.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


